CHAR
Charlton Aria Acquisition Corporation
There isn't enough reported data to score CHAR yet.
CHAR Fundamentals
| Metric | Status |
|---|---|
| Unavailable | |
| Healthy | |
| N/A | |
| N/A |
CHAR's profitability is currently healthy. There isn't enough data to rate its revenue. Free cash flow and net leverage aren't meaningful measures for financial services companies like CHAR.
CHAR PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 40x | $7.63 | -31% |
| Fair | 41x | $7.72 | -30% |
| Expensive | 44x | $8.29 | -25% |
| Current | 59x | $10.99 | — |
Historical ranges are pointers, not guarantees.
CHAR's PE is 59x, but its earnings don't support one, so it isn't a reliable read right now.
CHAR Forward outlook
There aren't enough analyst estimates for CHAR to show an outlook.
CHAR Earnings Per Share
CHAR Quarterly Revenue
CHAR's revenue is shrinking: $0 last quarter.
CHAR Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$272.6K | -$234.7K |
| Q2 2026 | -$240.1K | -$102.5K |
| Q1 2026 | -$42.5K | +$218.6K |
| Q4 2025 | -$106.5K | -$106.3K |
| Q1 2025 | -$261.2K | -$261.2K |
CHAR's free cash flow was −$661,692 over the past year, against −$436,872 the year before. Free cash flow isn't a meaningful measure for financial services companies like CHAR.
CHAR Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -38% | -3.3M shares |
| 1 year | -38% | -3.3M shares |
CHAR has 5M diluted shares, down 38% from a year ago.
| Quarter | Spent |
|---|---|
| Q2 2026 | — |
| Q1 2026 | — |
| Q4 2025 | — |
| Q3 2025 | — |
| Q2 2025 | — |
| Q1 2025 | — |
| Q4 2024 | — |
| Q1 2024 | — |
CHAR Net Leverage
CHAR Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 70.5 | Overbought |
| Stochastic | 19.1 | Oversold |
CHAR's weekly RSI is 71 (overbought) and its Stochastic is 19 (oversold).
CHAR PE vs Financial Services Sector
| Metric | CHAR | Sector median | Relative |
|---|---|---|---|
| PE | 59x | 13x | 353% above |
| PE % | 100 | 22 | 78 pts above |
CHAR is trading at 59x earnings, a 353% premium to the Financial Services sector's median of 13x, though its earnings don't support one.
CHAR Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $11.0 | 0.1% above |
| 20 week MA | $10.9 | 0.5% above |
| 50 week MA | $10.7 | 2.4% above |
| 100 week MA | $10.5 | 5% above |
CHAR is in an uptrend: it's above all four of its weekly moving averages, and 5% above its 100-week average.
CHAR Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2024 | $9.90 | $9.94 | +0.4% |
| 2025 | $9.94 | $10.5 | +5.1% |
| 2026 YTD | $10.5 | $11.0 | +5.2% |
CHAR has finished every year since 2024 higher, and it's up 5.2% so far in 2026.